Livzon Pharmaceutical Group Inc. (000513.SZ) announced that, as of July 31, 2024, the company repurchased a total of 4.8942 million A-shares through centralized bidding trading, accounting for 0.53% of the company's total share capital. The highest purchase price is RMB 36.80/share, and the lowest purchase price is RMB 32.95/share. The total amount of funds used is RMB 0.172 billion yuan (excluding transaction costs).
丽珠集团(000513.SZ)：累计耗资1.72亿元回购489.42万股
Livzon Pharmaceutical Group Inc. (000513.SZ) has spent a total of 0.172 billion yuan to repurchase 4.8942 million shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.